• 1. Order–disorder phenomena. Part 2.—Order–disorder phase equilibria in D- and L-systems of camphor and related compounds
  Chodziwadziwa C. Mjojo J. Chem. Soc. Faraday Trans. 2 1979 75 692
• 2. Dielectric studies of orientational disorder in D- and L-systems of camphor and camphoric anhydride
  Chodziwadziwa C. Mjojo,Harold K. Welsh J. Chem. Soc. Faraday Trans. 1992 88 2909
• 3. CXXXVII.—Morphotropic relationships between racemic compounds and their optically active components
  George Jerusalem J. Chem. Soc. Trans. 1912 101 1268
• 4. Topochemistry. Part XXI. The crystal and molecular structures of trans,trans-sorbamide
  S. E. Filippakis,L. Leiserowitz,G. M. J. Schmidt J. Chem. Soc. B 1967 297
• 5. Identification of organic extractables from commercial resin-modified glass-ionomers using HPLC-MS
  Rafal Rogalewicz,Kalina Batko,Adam Voelkel J. Environ. Monit. 2006 8 750

Introduction to DL-Camphoric Anhydride (CAS No. 595-30-2)

DL-Camphoric anhydride, with the chemical name (1R,3S,5S)-3,5-dimethyl-2-(1-methylethyl)-bicyclo[3.1.0]hexane-2-one, is a compound of significant interest in the field of organic chemistry and pharmaceutical research. Its CAS number, 595-30-2, uniquely identifies it in scientific literature and databases, facilitating precise referencing and study. This bicyclic ketone derivative is renowned for its versatile applications, particularly in the synthesis of chiral compounds and as an intermediate in drug development.

The molecular structure of DL-Camphoric anhydride features a camphor-like framework, characterized by a bridged bicyclic system with two methyl groups and an isopropyl group substituents. This configuration imparts unique steric and electronic properties, making it a valuable building block in medicinal chemistry. The compound's ability to exist as a racemic mixture (DL-form) allows researchers to explore both enantiomers, providing insights into stereoselectivity and pharmacological activity.

In recent years, DL-Camphoric anhydride has garnered attention for its role in the synthesis of biologically active molecules. Its rigid bicyclic core serves as a scaffold for constructing complex structures, enabling the development of novel therapeutic agents. For instance, studies have demonstrated its utility in the preparation of protease inhibitors and kinase inhibitors, which are critical targets in oncology and infectious disease treatment. The compound's reactivity also makes it suitable for derivatization into esters, amides, and other functionalized derivatives, further expanding its synthetic potential.

One of the most compelling aspects of DL-Camphoric anhydride is its application in asymmetric synthesis. Researchers have leveraged its chiral center to develop catalytic systems that enhance enantioselectivity in organic transformations. This has led to more efficient routes for producing enantiomerically pure compounds, which are often required for pharmaceutical applications due to their improved efficacy and reduced side effects. The compound's compatibility with various catalytic systems, including transition metal catalysts and biocatalysts, underscores its versatility as a synthetic intermediate.

The pharmaceutical industry has also explored DL-Camphoric anhydride for its potential as a prodrug or adjuvant. Prodrug strategies involve converting a less soluble or inactive drug into a more soluble and bioactive form upon administration. DL-Camphoric anhydride's ability to undergo hydrolysis or other metabolic transformations makes it an attractive candidate for such applications. Additionally, its structural motif has been incorporated into adjuvants designed to enhance immune responses in vaccine formulations.

Recent advances in computational chemistry have further illuminated the utility of DL-Camphoric anhydride. Molecular modeling studies have revealed insights into its interactions with biological targets, aiding in the rational design of drug candidates. These simulations have helped predict binding affinities and optimize molecular structures for improved pharmacokinetic properties. The integration of experimental data with computational methods has provided a more comprehensive understanding of how DL-Camphoric anhydride functions in complex biological systems.

The agrochemical sector has not been left behind in exploring the potential of DL-Camphoric anhydride either. Its structural features make it a viable candidate for developing novel pesticides and herbicides that target specific enzymatic pathways in pests while minimizing environmental impact. By modifying its functional groups or incorporating it into larger molecular frameworks, researchers aim to create compounds that offer enhanced efficacy and selectivity.

Environmental considerations also play a role in the research involving DL-Camphoric anhydride. Efforts are underway to develop greener synthetic routes that reduce waste and energy consumption without compromising yield or purity. These initiatives align with broader trends in sustainable chemistry, emphasizing the importance of environmentally responsible practices in chemical manufacturing.

Despite these advancements, challenges remain in fully harnessing the potential of DL-Camphoric anhydride. Issues such as scalability of synthesis and optimization of reaction conditions are critical areas of focus for industrial applications. Collaborative efforts between academia and industry are essential to address these challenges and translate laboratory discoveries into practical solutions.

In conclusion, DL-Camphoric anhydride (CAS No. 595-30-2) represents a fascinating compound with diverse applications across multiple scientific disciplines. Its unique structural features and reactivity make it indispensable in pharmaceutical research, catalysis, agrochemistry, and environmental science. As our understanding of its properties continues to evolve through interdisciplinary collaboration, DL-Camphoric anhydride is poised to play an even greater role in shaping future advancements.

• 2938-48-9(2,2-Dimethylglutaric anhydride)
• 595-29-9(3-Oxabicyclo[3.2.1]octane-2,4-dione,1,8,8-trimethyl-, (1R,5S)-)
• 115942-54-6(3,3,4,4,5,5-hexamethyloxane-2,6-dione)
• 6054-16-6(3-Oxabicyclo3.2.1octane-2,4-dione)
• 76-32-4(DL-Camphoric anhydride)
• 90820-47-6(3-oxabicyclo[3.2.1]octan-2-one, 5,8,8-trimethyl-, (±)-)
• 595-31-3(3-Oxabicyclo[3.2.1]octane-2,4-dione,1,8,8-trimethyl-, (1S,5R)-)
• 6053-46-9(Tetrahydro-1H-5,9-methanopyrano3,4-doxepine-1,3,6,8(4H)-tetraone)
• 507-96-0
• 5623-91-6